|
|
 |
|
Viewing report
|
|
|
|
Active Biotech AB (ACTI) - Financial and Strategic SWOT Analysis Review
GlobalData, Aug 2011, Pages: 38
Active Biotech AB (ACTI) - Financial and Strategic SWOT Analysis Review
Summary
Active Biotech AB (Active Biotech) is a Swedish biotechnology company that is specialized developing pharmaceuticals in the field of immunology. The company is primarily engaged in the research and development of products for the treatment of autoimmune/inflammatory diseases and cancer. The company’s portfolio includes innovative substances that modulate the human immune system. The company’s project portfolio consists five projects in clinical phase, of which three are related to drugs for the treatment of autoimmune diseases, such as MS, SLE, Crohn’s disease, Systemic Sclerosis and RA, and two of the projects focus on drugs for the treatment of cancer, mainly renal cell cancer and prostate cancer. Active Biotech is headquartered in Lund, Sweden.
Active Biotech AB Key Recent Developments…
Mar 15, 2011 Active Biotech Appoints Helen Tuvesso As Chief Scientific Officer
Jun 10, 2010 Active Biotech Capital Markets Day
May 17, 2010 Active Biotechs Prostate Cancer Project Tasq Featured In Molecular Cancer
Feb 10, 2010 Exploratory Data Presented For Active Biotechs Anyara Project
Feb 08, 2010 Teva, Active Biotech Amend Laquinimod Agreement
This comprehensive SWOT profile of Active Biotech AB provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Note: Some sections may be missing if data is unavailable for the company.
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Customers who bought this item also bought
Active Biotech AB - Product Pipeline Review - Q1 2011
Pevion Biotech Ltd - Strategic SWOT Analysis Review
Mycenax Biotech Inc. (4726) - Financial and Strategic SWOT Analysis Review
Actis Biologics, Inc - Product Pipeline Review - H2 2011
Marina Biotech, Inc. (MRNA) - Financial and Strategic SWOT Analysis Review
Orexo AB (ORX) - Financial and Strategic SWOT Analysis Review
Oncolytics Biotech Inc. (ONC) - Financial and Strategic SWOT Analysis Review
Hansa Medical AB (HMED) - Financial and Strategic SWOT Analysis Review
Actis Biologics, Inc - Product Pipeline Review - Q1 2011
Teva Pharmaceutical Industries Limited (TEVA) - Financial and Strategic SWOT Analysis Review
|
|
|
|
